An investigation of auto-reactivity after head injury

Journal of Neuroimmunology

Volumn 174, Issue 1-2, 2006, Pages 180-186

  Cox, A L ^a   Coles, A J ^a   Nortje, J ^a,b   Bradley, P G ^a,b   Chatfield, D A ^a,b   Thompson, S J ^a   Menon, D K ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autoimmunity; T lymphocytes; Traumatic brain injury

Indexed keywords

MYELIN; MYELIN BASIC PROTEIN;

ADULT; ARTICLE; AUTOIMMUNITY; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; DIAGNOSTIC IMAGING; FEMALE; HEAD INJURY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; MALE; NERVE CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TRAUMATIC BRAIN INJURY;

ADULT; AGE FACTORS; AUTOIMMUNITY; CASE-CONTROL STUDIES; CELL PROLIFERATION; CRANIOCEREBRAL TRAUMA; CYTOKINES; FEMALE; GLASGOW COMA SCALE; HUMANS; LYMPHOCYTES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELIN BASIC PROTEINS; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 33646110273     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.01.007     Document Type: Article

References (17)

1. Fee D., Crumbaugh A., Jacques T., Herdrich B., Sewell D., Auerbach D., Piaskowski S., Hart M.N., Sandor M., and Fabry Z. Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury. J. Neuroimmunol. 136 1-2 (2003) 54-66
2. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 4 (2003) 330-336
3. Givan A.L., Fisher J.L., Waugh M., Ernstoff M.S., and Wallace P.K. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J. Immunol. Methods 230 1-2 (1999) 99-112
4. Hauben E., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Akselrod S., Neeman M., Cohen I.R., and Schwartz M. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355 9200 (2000) 286-287
5. Ibarra A., Hauben E., Butovsky O., and Schwartz M. The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. Eur. J. Neurosci. 19 11 (2004) 2984-2990
6. Jennett B., and Bond M. Assessment of outcome after severe brain damage. Lancet 1 7905 (1975) 480-484
7. Kipnis J., Yoles E., Schori H., Hauben E., Shaked I., and Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci.: Off. J. Soc. Neurosci. 21 13 (2001) 4564-4571
8. Kipnis J., Mizrahi T., Hauben E., Shaked I., Shevach E., and Schwartz M. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc. Natl. Acad. Sci. 99 24 (2002) 15620-15625
9. Kipnis J., Mizrahi T., Hauben E., Shaked I., Shevach E., and Schwartz M. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc. Natl. Acad. Sci. 99 24 (2002) 15620-15625
10. Kipnis J., Yoles E., Mizrahi T., Ben Nur A., and Schwartz M. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. 130 1-2 (2002) 78-85
11. Lyons A.B., Hasbold J., and Hodgkin P.D. Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. Methods Cell Biol. 63 (2001) 375-398
12. McKenzie A.N., and Sanderson C.J. Interleukin-5. Chem. Immunol. 51 (1992) 135-152
13. MeinL E., Hoch R.M., Dornmair K., de Waal Malefyt R., Bontrop R.E., Jonker M., Lassmann H., Hohlfeld R., Wekerle H., and 't Hart B.A. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am. J. Pathol. 150 2 (1997) 445-453
14. Menon D.K. Cerebral protection in severe brain injury: physiological determinants of outcome and their optimisation. Br. Med. Bull. 55 1 (1999) 226-258
15. Pette M., Fujita K., Kitze B., Whitaker J.N., Albert E., Kappos L., and Wekerle H. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40 11 (1990) 1770-1776
16. Pette M., Fujita K., Kitze B., Whitaker J.N., Albert E., Kappos L., and Wekerle H. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40 11 (1990) 1770-1776
17. Teasdale G., and Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 2 7872 (1974) 81-84